Medication-info.com Search Menu

Styptstix Package Insert

Status:
Prescription (Rx) Facts
Strength:
38.21 mg, 12.74 mg
Other brand names:
Active ingredients:

Prescribing information (package insert) - Styptstix

INDICATIONS AND USAGE:

For cauterization of skin or mucous membrane and for removing warts and granulated tissue.

DOSAGE AND ADMINISTRATION:

Moisten the applicator tip with distilled, deionized or purified water and apply the silver nitrate to the affected area

by holding, rubbing, or rotating the tip along the affected tissue. The strength of the action is controlled by the dilution with

distilled, deionized or purified water. One silver nitrate applicator is generally sufficient for each application. The action of

the silver nitrate can be stopped by washing the area with saline solution (0.9% sodium chloride). Using saline solution to

wet the applicator tips, or residual saline from wound flushing/washing will interfere with the action of silver nitrate resulting

in cauterization failure. Only use distilled, deionized or purified water to wet applicator tips. Blot dry wounds that have been

flushed/washed with saline prior to applying silver nitrate.

DOSAGE FORMS AND STRENGTHS:

Stick: 50 mg

CONTRAINDICATIONS

Silver salts stain tissue black due to deposition of reduced silver. The stain gradually disappears within a period of two

weeks. Prolonged ingestion or absorption of silver compounds leads to deposition of silver in connective tissues, producing

a slate-blue discoloration of the skin known as argyria. This discoloration may also appear on mucous membranes such as

the margins of gums. The sclera of the eye is also stained.

WARNINGS AND PRECAUTIONS:

WARNING: KEEP OUT OF REACH OF CHILDREN. The active ingredients are poisonous and may be fatal when

ingested in sufficient doses. The symptoms include toxic gastroenteritis, which may lead to coma, convulsion,

paralysis and profound alteration of respiration. If poisoning occurs, immediately consult a physician.

WARNING: DO NOT USE ON THE EYES. In case of eye contact, hold eyes open and immediately flush

thoroughly with water for at least 15 minutes and consult a physician.

CAUTION: SILVER NITRATE IS A CAUSTIC SUBSTANCE. Chemical burns may result from inappropriate use of

product.

  • Wear chemical resistant gloves while using this product. Wear other appropriate personal protective equipment as

needed.

  • Take care to confine the silver nitrate to the area being treated by using an appropriate physical or chemical barrier to

prevent staining or burning of untreated tissue.

  • Skin contact time with applicators should be minimal when used on thin delicate skin or neonates.
  • Avoid prolonged contact with skin or other surfaces since staining may occur.

CAUTION: FEDERAL LAW PROHIBITS DISPENSING WITHOUT PRESCRIPTION.

STORAGE:

Store in the closed package at room temperature in a dry place protected from light. Silver nitrate will oxidize

and turn dark brown upon exposure to light, however this does not affect the product’s potency or utility.

Exposure to moisture can cause the tip to break or loosen from the applicator. Store away from vaporous

chemicals.

DISPOSAL:

Expired or unused applicators may be disposed of according to applicable federal, state and local regulations.

About this document

Source: FDA drug labeling via NLM DailyMed · View the label on DailyMed

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Styptstix

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Active ingredients Silver nitrate 38.21 mg, Potassium nitrate 12.74 mg
Dosage form Stick
Route Topical
Marketing status listed in the FDA NDC Directory
Company (applicant) Henry Schein Inc.
FDA approval UNAPPROVED DRUG OTHERUnapproved drug
Manufacturers 1 labelers list this drug on DailyMed
Packages (NDC)
Package
38.21 mg, 12.74 mg – 100 in 1 tube NDC 0404-1000-03

Source: FDA drug labeling via NLM DailyMed, data as of October 31, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.